S&P 500   3,257.34 (-1.16%)
DOW   28,656.25 (-1.15%)
QQQ   219.09 (-1.62%)
AAPL   310.78 (-2.37%)
MSFT   163.15 (-1.15%)
GOOGL   1,434.66 (-2.15%)
AMZN   1,838.52 (-1.24%)
CGC   21.90 (-3.31%)
NVDA   241.33 (-3.66%)
BABA   207.29 (-3.02%)
MU   55.77 (-3.45%)
GE   11.54 (-1.54%)
TSLA   554.30 (-1.86%)
AMD   49.59 (-1.51%)
T   38.55 (+0.13%)
ACB   1.93 (-3.02%)
F   8.93 (-0.78%)
NFLX   344.87 (-2.35%)
BAC   33.11 (-1.31%)
DIS   136.96 (-2.23%)
GILD   63.71 (+0.89%)
S&P 500   3,257.34 (-1.16%)
DOW   28,656.25 (-1.15%)
QQQ   219.09 (-1.62%)
AAPL   310.78 (-2.37%)
MSFT   163.15 (-1.15%)
GOOGL   1,434.66 (-2.15%)
AMZN   1,838.52 (-1.24%)
CGC   21.90 (-3.31%)
NVDA   241.33 (-3.66%)
BABA   207.29 (-3.02%)
MU   55.77 (-3.45%)
GE   11.54 (-1.54%)
TSLA   554.30 (-1.86%)
AMD   49.59 (-1.51%)
T   38.55 (+0.13%)
ACB   1.93 (-3.02%)
F   8.93 (-0.78%)
NFLX   344.87 (-2.35%)
BAC   33.11 (-1.31%)
DIS   136.96 (-2.23%)
GILD   63.71 (+0.89%)
S&P 500   3,257.34 (-1.16%)
DOW   28,656.25 (-1.15%)
QQQ   219.09 (-1.62%)
AAPL   310.78 (-2.37%)
MSFT   163.15 (-1.15%)
GOOGL   1,434.66 (-2.15%)
AMZN   1,838.52 (-1.24%)
CGC   21.90 (-3.31%)
NVDA   241.33 (-3.66%)
BABA   207.29 (-3.02%)
MU   55.77 (-3.45%)
GE   11.54 (-1.54%)
TSLA   554.30 (-1.86%)
AMD   49.59 (-1.51%)
T   38.55 (+0.13%)
ACB   1.93 (-3.02%)
F   8.93 (-0.78%)
NFLX   344.87 (-2.35%)
BAC   33.11 (-1.31%)
DIS   136.96 (-2.23%)
GILD   63.71 (+0.89%)
S&P 500   3,257.34 (-1.16%)
DOW   28,656.25 (-1.15%)
QQQ   219.09 (-1.62%)
AAPL   310.78 (-2.37%)
MSFT   163.15 (-1.15%)
GOOGL   1,434.66 (-2.15%)
AMZN   1,838.52 (-1.24%)
CGC   21.90 (-3.31%)
NVDA   241.33 (-3.66%)
BABA   207.29 (-3.02%)
MU   55.77 (-3.45%)
GE   11.54 (-1.54%)
TSLA   554.30 (-1.86%)
AMD   49.59 (-1.51%)
T   38.55 (+0.13%)
ACB   1.93 (-3.02%)
F   8.93 (-0.78%)
NFLX   344.87 (-2.35%)
BAC   33.11 (-1.31%)
DIS   136.96 (-2.23%)
GILD   63.71 (+0.89%)
Log in

NASDAQ:CHTP - Chelsea Therapeutics International Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Chelsea Therapeutics International, Ltd. is a development stage pharmaceutical company that focuses on acquiring, developing and commercializing products for the treatment of a variety of human diseases. The Company is developing a therapeutic agent for the treatment of symptomatic neurogenic orthostatic hypotension (NOH), associated with primary autonomic failure and falls related to NOH in Parkinson's Disease (PD), as well as other norepinephrine-related conditions and diseases, including intradialytic hypotension (IDH), fibromyalgia, adult attention deficit hyperactivity disorder (ADHD), chronic fatigue syndrome (CFS), freezing of gait in PD and Down syndrome. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:CHTP
CUSIPN/A
Phone+1-704-3411516

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive CHTP News and Ratings via Email

Sign-up to receive the latest news and ratings for CHTP and its competitors with MarketBeat's FREE daily newsletter.


Chelsea Therapeutics International (NASDAQ:CHTP) Frequently Asked Questions

What is Chelsea Therapeutics International's stock symbol?

Chelsea Therapeutics International trades on the NASDAQ under the ticker symbol "CHTP."

Has Chelsea Therapeutics International been receiving favorable news coverage?

News coverage about CHTP stock has been trending somewhat negative this week, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Chelsea Therapeutics International earned a media sentiment score of -1.4 on InfoTrie's scale. They also gave media headlines about the healthcare company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for Chelsea Therapeutics International.

What other stocks do shareholders of Chelsea Therapeutics International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chelsea Therapeutics International investors own include Avanir Pharmaceuticals (AVNR), Dynavax Technologies (DVAX), CytRx (CYTR), SLS International (SLS), Ariad Pharmaceuticals (ARIA), Avid Bioservices (CDMO), DryShips (DRYS), Intel (INTC), Plug Power (PLUG) and Rexahn Pharmaceuticals (REXN).

What is Chelsea Therapeutics International's official website?

The official website for Chelsea Therapeutics International is http://www.chelseatherapeutics.com/.

How can I contact Chelsea Therapeutics International?

Chelsea Therapeutics International's mailing address is 3530 Toringdon Way Ste 200, CHARLOTTE, NC 28277-3436, United States. The healthcare company can be reached via phone at +1-704-3411516.


MarketBeat Community Rating for Chelsea Therapeutics International (NASDAQ CHTP)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  114 (Vote Outperform)
Underperform Votes:  87 (Vote Underperform)
Total Votes:  201
MarketBeat's community ratings are surveys of what our community members think about Chelsea Therapeutics International and other stocks. Vote "Outperform" if you believe CHTP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CHTP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/27/2020 by MarketBeat.com Staff

Featured Article: Neutral Rating

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel